Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11

Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11

Bibliografische gegevens
Parent link:	Molecules.— .— Basel: MDPI AG Vol. 30, iss. 11.— 2025.— Article number 2353, 26 p.
Andere auteurs:	Plotnikov M. B., Anishchenko A. M., Khlebnikov A. I. Andrey Ivanovich, Schepetkin I. A. Igor
Samenvatting:	Title screen Disruption of the blood–brain barrier (BBB) accompanies many brain diseases, including stroke, neurodegenerative diseases, and brain tumors, leading to swelling, increased neuroinflammation, and neuronal death. In recent years, it has become clear that the c-Jun N-terminal kinase (JNK) signaling pathway is involved in disruption of the structural integrity of the BBB. Activation of the JNK signaling pathway has a negative effect on the functioning of the cellular elements of the neurovascular unit that form the BBB. The aim of this review is to assess the role of the JNK signaling pathway in the disruption of the structural integrity of the BBB in animal models of stroke (MCAO/R, middle cerebral artery occlusion with reperfusion), Alzheimer’s disease, and brain tumors and to analyze the effects of compounds of various natures that directly or indirectly affect the activity of the JNK signaling pathway. These compounds can reduce damage to the BBB and brain edema, reduce neuroinflammation and oxidative stress, reduce the expression of proapoptotic factors, and increase the expression of tight junction proteins. Certain compounds mitigate BBB dysfunction, being promising candidates for neuroprotective therapies. These agents exert their effects, in part, through inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway, a mechanism linked to reduced neuronal damage and improved BBB integrity Текстовый файл
Taal:	Engels
Gepubliceerd in:	2025
Onderwerpen:	Alzheimer’s disease blood–brain barrier brain tumor ischemia/reperfusion c-Jun N-terminal kinase (JNK) JNK pathway JNK inhibitor электронный ресурс труды учёных ТПУ
Online toegang:	https://doi.org/10.3390/molecules30112353
Formaat:	Elektronisch Hoofdstuk
KOHA link:	https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=682272

Gelijkaardige items

c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Gepubliceerd in: (2019)

c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Gepubliceerd in: (2018)

Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Gepubliceerd in: (2019)

JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S; Biochemistry (Moscow); Vol. 90, iss. 2
Gepubliceerd in: (2025)

Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Gepubliceerd in: (2020)

Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Gepubliceerd in: (2019)

The IQ-1S JNK (c-Jun N-Terminal Kinase) Inhibitor Suppresses Premature Aging of OXYS Rat Brain; Neurochemical Journal; Vol. 17, iss. 3
Gepubliceerd in: (2023)

Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S); Cells; Vol. 14, iss. 12
Gepubliceerd in: (2025)

Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Gepubliceerd in: (2024)

Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Gepubliceerd in: (2024)

c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Gepubliceerd in: (2025)

Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation; Cells; Vol. 9, iss. 11
Gepubliceerd in: (2020)

Research on neural network analysis of MRI images of the brain for the diagnosis of brain diseases; Молодежь и современные информационные технологии
door: Tekere R. Richard
Gepubliceerd in: (2025)

Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Gepubliceerd in: (2023)

Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Gepubliceerd in: (2023)

Оксим инденохиноксалинона IQ-1 как перспективный агент для разработки лекарственных препаратов; Перспективы развития фундаментальных наук; Т. 2 : Химия
door: Коврижина А. Р. Анастасия Руслановна
Gepubliceerd in: (2024)

Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Gepubliceerd in: (2023)

Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia; Frontiers in Chemistry; Vol. 9
Gepubliceerd in: (2021)

Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Gepubliceerd in: (2023)

A review of Brain-Computer Interface technology; Control and Communications (SIBCON)
door: Stankevich Ph. V. Philippe Vladimirovich
Gepubliceerd in: (2015)

Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats; Bulletin of Experimental Biology and Medicine; Vol. 175, iss. 6
Gepubliceerd in: (2023)

Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1; European Polymer Journal; Vol. 127
Gepubliceerd in: (2020)

Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Gepubliceerd in: (2020)

Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Gepubliceerd in: (2021)

Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Gepubliceerd in: (2023)

Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines; Molecules; Vol. 29, iss. 11
Gepubliceerd in: (2024)

Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Gepubliceerd in: (2018)

Brain Tractography in Diabetes Mellitus and Cognitive Impairments; Neuroscience and Behavioral Physiology; Vol. 51, No. 6
Gepubliceerd in: (2021)

Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Gepubliceerd in: (2022)

Interhemispheric asymmetry of the brain in patients with type 1 diabetes mellitus and cognitive impairment; Frontiers in Endocrinology; Vol. 13
Gepubliceerd in: (2022)

Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats; Hypertension Research; Vol. 43
Gepubliceerd in: (2020)

An Efficient Hybrid Fuzzy-Clustering Driven 3D-Modeling of Magnetic Resonance Imagery for Enhanced Brain Tumor Diagnosis; Electronics; Vol. 9, iss. 3
Gepubliceerd in: (2020)

Segmentation of brain MRI using an altruistic Harris Hawks’ Optimization algorithm; Knowledge-Based Systems; Vol. 232
Gepubliceerd in: (2021)

The Ischemic Stroke Casebook Clinical and Endovascular Approaches to Revascularization /
Gepubliceerd in: (2021)

Effect of Chronic Continuous Normobaric Hypoxia on Functional State of Cardiac Mitochondria and Tolerance of Isolated Rat Heart to Ischemia and Reperfusion: Role of µ and delta2 Opioid Receptors; Physiological Research; Vol. 68, iss. 6
Gepubliceerd in: (2019)

Comparative Evaluation of Neuroprotective Activity of Tryptanthrin and Its Oxime in Middle Cerebral Artery Occlusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 177, iss. 3
Gepubliceerd in: (2024)

Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Gepubliceerd in: (2022)

Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial; The Journal of Thoracic and Cardiovascular Surgery; Vol. ХХХ
Gepubliceerd in: (2018)

Music influence on athlete`s sportsmanship (from the example ofsynchronized figure skating athletes); Journal of Economics and Social Sciences; № 12
door: Bredikhina Yu. P. Yuliya Petrovna
Gepubliceerd in: (2018)

Электроэнцефалограф на наносенсорах для регистрации биопотенциалов мозга в диапазоне частот до 10КГЦ; Ресурсоэффективные системы в управлении и контроле: взгляд в будущее (т. 2)
Gepubliceerd in: (2018)